pmc logo imageJournal ListSearchpmc logo image
Logo of opendentjJournal URL: redirect3.cgi?&&auth=0daqMy7MZxfMOpxDLWi3cGVvBP62HmvZkBk6b1Q96&reftype=publisher&article-id=2581531&issue-id=173529&journal-id=688&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.bentham.org/open/todentj/index.htm
Open Dent J. 2008; 2: 24–29.
Published online 2008 February 21. doi: 10.2174/1874210600802010024.
PMCID: PMC2581531
Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis
L. Montebugnoli,1* L. Felicetti,1 D.B. Gissi,1 F. Cervellati,1 D. Servidio,1 C. Marchetti,1 C. Prati,1 F. Flamminio,2 and M.P. Foschini2
1Department of Oral Science, University of Bologna
2Section of Anatomic Pathology at Bellaria Hospital, University of Bologna, Italy
*Address correspondence to this author at the Department of Oral Science, University of Bologna, Italy; E-mail: lucio.montebugnoli/at/unibo.it
Received November 13, 2007; Accepted January 9, 2008.
Abstract
p53 over-expression has been proposed as a reliable marker associated to oral carcinogenesis, although only about 50% of oral carcinomas (OSCC) are associated with p53 over-expression and even p53-negative lesions can progress to OSCC. The aim of the study was to determine whether the combination of p53 over-expression and p53 low-expression associated with Ki67 over-expression (high Ki67/p53 ratio) could lead to a more sensitive parameter. Immunohistochemical expression of Ki67 and p53 was measured in 54 specimens from OSCC; 27 specimens from moderate/severe epithelial dysplasia; 32 specimens from oral leukoplakias without epithelial dysplasia, and 13 specimens with normal epithelium. p53 over-expression was found in 31 (53%) samples from OSCC, in 10 (37%) samples from severe dysplasias, and in 5 (15%) samples from non-dysplastic lesions, while the combination of high p53 values with high Ki67/p53 ratio was observed in 93% of OSCC, in 81% of dysplastic lesions, and in 50% of non-dysplastic lesions. This parameter may have a clinical implication to detect early lesions with an impairment of p53 pathway, and probably at risk of progress to OSCC.